The sedimentation of radiolabelled 22 nm hepatitis B surface antigen particles was unaffected by treatment with either trypsin or SDS alone, but combined treatment disrupted the particulate nature of the radiolabelled material. Considerable antibody binding activity by the group-specific determinant (a) was preserved after combined SDS and trypsin treatment but was released from the bulk of the radiolabelled protein; gel filtration indicated an approximate mol. wt. of 5000 to 15000 for the released antibody binding material. This material was precipitated by concanavalin A, suggesting the presence of carbohydrate. Its serological activity was remarkably resistant to boiling and to proteolytic digestion, but was partially sensitive to treatment with 0.01 m-periodate or with mixed carbohydrases and neuraminidase, and was greatly reduced by treatment with reducing agent. These data suggest that the stability of the a determinant is due to the structure of the antibody binding site itself, rather than to involvement in the quaternary structure of the particle, and that intact disulphide bonds and carbohydrate, closely related to the antibody binding site, are necessary for the full expression of serological activity.
DreesmanG. R.,
ChairezR.,
SuarezM.,
HollingerF. B.,
CourtneyJ.,
MelnickJ. L.1975; Production of antibody to individual polypeptides derived from purified hepatitis B surface antigen. Journal of Virology 16:508–515
DreesmanG. R.,
HollingerF. B.,
MccombsR. M.,
MelnickJ. L.1973; Alteration of hepatitis B antigen (HB Ag) determinants by reduction and alkylation. Journal of General Virology 19:129–134
GoldsteinI. J.,
SoL.1965; Protein–carbohydrate interaction. III. Agar gel-diffusion studies on the interaction of concanavalin A, a lectin isolated from jack bean, with polysaccharides. Archives of Biochemistry and Biophysics 11:407–414
ImaiM.,
GotohA.,
NishiokaK.,
KurashinaS.,
MiyakawaY.,
MayumiM.1974; Antigenicity of reduced and alkylated Australia antigen. Journal of Immunology 112:614–419
KrugmanS.,
GilesJ. P.1973; Viral hepatitis, type B (MS-2 strain). Further observations on natural history and prevention. New England Journal of Medicine 288:755–760
Le BouvierG. L.1972; Seroanalysis by immunodiffusion: the subtypes of type B hepatitis virus. In Hepatitis and Blood Transfusion pp 97–109 Edited by
VyasG. N.,
PerkinsH. A.,
SchmidR.
New York and London: Grune and Stratton;
Le BouvierG. L.,
MccollumR. W.1970; Australia (hepatitis–associated) antigen physic-chemical and immunological characteristics. Advances in Virus Research 16:357–396
RaoK. R.,
VyasG. N.1974a; Structure and activity of hepatitis B antigen (HB Ag). I. Studies on some conformational aspects and chemical modification of hepatitis B antigen. Microbios 9:239–245
RaoK. R.,
VyasG. N.1974b; Structure and activity of hepatitis B antigen (HB Ag). 2. Amino acid composition of an active subunit of HB Ag. Microbios 10:233–238
ShihJ. W.-K.,
GerinJ. L.1975; Immunochemistry of hepatitis B surface antigen (HBsAg): preparation and characterisation of antibodies to the constituent polypeptides. Journal of Immunology 115:634–639
SukenoN.,
ShirachiR.,
YamaguchiJ.,
IshidaN.1972; Reduction and reoxidation cf Australia antigen: loss and reconstitution of particle structure and antigenicity. Journal of Virology 9:182–183
VyasG. N.,
RaoK. R.,
IbrahimA. B.1972; Australia antigen (hepatitis B antigen): a conformational antigen dependent on disulfide bonds. Science, New York 178:1300–1301